Pronomz Ventures LLP, along with related PACs, has increased its stake in Onesource Specialty Pharma Limited by acquiring 33,906 equity shares through open market purchases. This acquisition raises the promoter group’s total holding to 3,46,05,105 shares, representing 30.19% of the total share/voting capital. The transaction took place on January 30, 2026.
Promoter Group’s Increased Holding
Pronomz Ventures LLP, acting as the acquirer, along with several Persons Acting in Concert (PACs), including Karuna Business Solutions LLP and Tenshi Pharmaceuticals Private Limited, has increased their stake in Onesource Specialty Pharma Limited. The total number of shares acquired is 33,906.
Details of the Acquisition
The acquisition was executed via open market purchases. Before this transaction, the promoter group held 3,45,71,199 shares, representing 30.17% of the total share/voting capital. After the acquisition, the total holding has increased to 3,46,05,105 shares, equivalent to 30.19% of the total share/voting capital.
Impact on Share Capital
The equity share capital of Onesource Specialty Pharma Limited remains unchanged at 11,46,21,201 equity shares of Rs. 1 each, fully paid up, both before and after the acquisition. The diluted share/voting capital also remains the same.
Source: BSE
